TRIAZOLAM Side Effects

6860695-X | Anxiety, Insomnia, Transient Ischaemic Attack
on Jul 19, 2010 Female patient from UNITED STATES , 60 years of age, weighting 143.0 lb, was diagnosed with sleep disorder (What is sleep disorder?) and was treated with Triazolam (View Usage). Patient experienced the following unwanted or unexpected effects: anxiety (What is anxiety?), insomnia, transient ischaemic attack. Triazolam dosage: 2 Bedtime. During the same period patient was treated with DIAZEPAM (View Diazepam Review and Diazepam Label ). Patient was hospitalized.

6792758-1 | Ageusia, Anxiety, Hypoaesthesia Oral
Patient was taking Triazolam (View Usage). Patient had the following side effects: ageusia, anxiety (What is anxiety?), hypoaesthesia oral on Sep 30, 2008 from UNITED STATES Additional patient health information: Female patient , 64 years of age, . Triazolam dosage: .

6738576-1 | Electrocardiogram Qt Prolonged, Ventricular Extrasystoles
Adverse event was reported on May 12, 2010 by a Female patient taking Triazolam (View Usage) (Dosage: 0.125 Mg, Unk) . Location: JAPAN , 25 years of age, weighting 81.57 lb, After Triazolam was administered, patient had the following side effects: electrocardiogram qt prolonged, ventricular extrasystoles. During the same period patient was treated with SULPIRIDE (200 Mg, Unk) (View Sulpiride Review and Sulpiride Label ), FLUVOXAMINE MALEATE (150 Mg, Unk) (View Fluvoxamine Maleate Review and Fluvoxamine Maleate Label ), PEROSPIRONE (4 Mg, Unk) (View Perospirone Review and Perospirone Label ), FLUNITRAZEPAM (2 Mg, Unk) (View Flunitrazepam Review and Flunitrazepam Label ).

6731034-X | Abnormal Dreams, Hallucination
on May 05, 2010 Female patient from , 87 years of age, was diagnosed with insomnia and was treated with Triazolam (View Usage). Patient experienced the following unwanted or unexpected effects: abnormal dreams, hallucination. Triazolam dosage: 0.25 Mg.


6722409-3 | Electrocardiogram Qt Prolonged, Hypotension, Intentional Overdose, Sinus Bradycardia, Suicide Attempt, Torsade De Pointes
on May 10, 2010 Male patient from , 60 years of age, was diagnosed with bradycardia, hypotension and was treated with Triazolam (View Usage). Patient had the following side effects: electrocardiogram qt prolonged, hypotension, intentional overdose, sinus bradycardia, suicide attempt, torsade de pointes. Triazolam dosage: . During the same period patient was treated with EPERISONE (View Eperisone Review and Eperisone Label ), NIFEDIPINE (40 Mg) (View Nifedipine Review and Nifedipine Label ), ATROPINE (0.5 Mg) (View Atropine Review and Atropine Label ), DOPAMINE HCL (View Dopamine Hcl Review and Dopamine Hcl Label ). Patient was hospitalized.

6694054-X | Abnormal Dreams, Hallucination
Patient was taking Triazolam (View Usage). After Triazolam was administered, patient had the following side effects: abnormal dreams, hallucination on Apr 21, 2010 from Additional patient health information: Female patient , 87 years of age, was diagnosed with insomnia and. Triazolam dosage: 0.25 Mg.

6644614-7 | Electrocardiogram Qt Prolonged, Intentional Overdose, Suicide Attempt, Torsade De Pointes
Adverse event was reported on Mar 10, 2010 by a Male patient taking Triazolam (View Usage) (Dosage: 2.5 Mg) . Location: JAPAN , 60 years of age, Patient experienced the following unwanted or unexpected effects: electrocardiogram qt prolonged, intentional overdose, suicide attempt, torsade de pointes. During the same period patient was treated with EPERISONE (5000 Mg) (View Eperisone Review and Eperisone Label ), NIFEDIPINE (40 Mg, 1x/day) (View Nifedipine Review and Nifedipine Label ).

6638135-5 | Urticaria
on Mar 15, 2010 Female patient from UNITED STATES , 28 years of age, weighting 191.4 lb, was diagnosed with insomnia and was treated with Triazolam (View Usage). Patient had the following side effects: urticaria. Triazolam dosage: 0.25mg At Bedtime Oral.

6395448-2 | Delirium, Withdrawal Syndrome
on Sep 30, 2009 Female patient from JAPAN , 80 years of age, was diagnosed with insomnia and was treated with Triazolam (View Usage). After Triazolam was administered, patient had the following side effects: delirium, withdrawal syndrome. Triazolam dosage: 0.125 - 0.25 Mg, Every Day. Patient was hospitalized.

6284802-5 | Intentional Overdose, Multi-organ Failure
Patient was taking Triazolam (View Usage). Patient experienced the following unwanted or unexpected effects: intentional overdose, multi-organ failure on Jul 15, 2009 from JAPAN Additional patient health information: Female patient , 15 years of age, . Triazolam dosage: 0.25 Mg, 6 Df. During the same period patient was treated with FERROUS CITRATE (50 Mg, 30 Df) (View Ferrous Citrate Review and Ferrous Citrate Label ), REBAMIPIDE (100 Mg, 60 Df) (View Rebamipide Review and Rebamipide Label ), FLUNITRAZEPAM (2 Mg, 10 Df) (View Flunitrazepam Review and Flunitrazepam Label ).

6273342-5 | Abnormal Behaviour, Crying, Dyskinesia, Inappropriate Affect, Memory Impairment, Therapeutic Response Unexpected
Adverse event was reported on Jul 13, 2009 by a Female patient taking Triazolam (View Usage) (Dosage: 0.25 Mg) was diagnosed with insomnia, circadian rhythm sleep disorder and. Location: , 14 years of age, Patient had the following side effects: abnormal behaviour, crying, dyskinesia, inappropriate affect, memory impairment, therapeutic response unexpected. During the same period patient was treated with VITAMIN B 12 (View Vitamin B-12 Review and Vitamin B-12 Label ), MELATONIN (3 Mg) (View Melatonin Review and Melatonin Label ), BROTIZOLAM (0.25 Mg) (View Brotizolam Review and Brotizolam Label ).

6157647-4 | Unevaluable Event
on Apr 14, 2009 Female patient from UNITED STATES , 46 years of age, weighting 150.0 lb, was diagnosed with tooth disorder (What is tooth disorder?) and was treated with Triazolam (View Usage). After Triazolam was administered, patient had the following side effects: unevaluable event. Triazolam dosage: 2 Tablets Once Po.

5810457-7 | Coeliac Disease, Depression, Oedema
on Jul 03, 2008 Female patient from UNITED STATES , weighting 135.1 lb, was diagnosed with hypertension, depression (What is depression?), thyroid disorder and was treated with Triazolam (View Usage). Patient experienced the following unwanted or unexpected effects: coeliac disease, depression (What is depression?), oedema. Triazolam dosage: . During the same period patient was treated with AMLODIPINE (View Amlodipine Review and Amlodipine Label ), EFFEXOR (View Effexor Review and Effexor Label ), COZAAR (View Cozaar Review and Cozaar Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), METFORMIN (View Metformin Review and Metformin Label ), CENTRUM SILVER (View Centrum Silver Review and Centrum Silver Label ).

5761853-8 | Coeliac Disease, Depression, Oedema
Patient was taking Triazolam (View Usage). Patient had the following side effects: coeliac disease, depression (What is depression?), oedema on May 27, 2008 from UNITED STATES Additional patient health information: Female patient , weighting 135.3 lb, was diagnosed with hypertension, depression (What is depression?), thyroid disorder and. Triazolam dosage: . During the same period patient was treated with AMLODIPINE (View Amlodipine Review and Amlodipine Label ), EFFEXOR (View Effexor Review and Effexor Label ), COZAAR (View Cozaar Review and Cozaar Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), CENTRUM SILVER (View Centrum Silver Review and Centrum Silver Label ).

5761775-2 | Hypertension, Knee Arthroplasty
Adverse event was reported on May 27, 2008 by a Female patient taking Triazolam (View Usage) (Dosage: ) was diagnosed with depression (What is depression?) and. Location: UNITED STATES , weighting 135.3 lb, After Triazolam was administered, patient had the following side effects: hypertension, knee arthroplasty. During the same period patient was treated with EFFEXOR (View Effexor Review and Effexor Label ), COZAAR (View Cozaar Review and Cozaar Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), CENTRUM SILVER (View Centrum Silver Review and Centrum Silver Label ), CITRUCEL (View Citrucel Review and Citrucel Label ).

5750315-X | Dyspnoea, Head Discomfort, Movement Disorder, Neuromyopathy, Paralysis
on May 21, 2008 Female patient from UNITED STATES , 63 years of age, weighting 185.0 lb, was diagnosed with insomnia, gastrooesophageal reflux disease and was treated with Triazolam (View Usage). Patient experienced the following unwanted or unexpected effects: dyspnoea, head discomfort, movement disorder (What is movement disorder?), neuromyopathy, paralysis (What is paralysis?). Triazolam dosage: 0.125mg 1/day At Night Po. During the same period patient was treated with OMEPRAZOLE (20mg 1/day In Morning Po) (View Omeprazole Review and Omeprazole Label ). Patient was hospitalized.

5565434-0 | Unevaluable Event
on Dec 06, 2007 Female patient from UNITED STATES , 88 years of age, was treated with Triazolam (View Usage). Patient had the following side effects: unevaluable event. Triazolam dosage: . Patient was hospitalized.

5397882-6 | Sedation
Patient was taking Triazolam (View Usage). After Triazolam was administered, patient had the following side effects: sedation on Jul 23, 2007 from UNITED STATES Additional patient health information: Male patient , 60 years of age, weighting 185.0 lb, was diagnosed with insomnia and. Triazolam dosage: One Time.

5344532-0 |
Adverse event was reported on May 23, 2007 by a Male patient taking Triazolam (View Usage) (Dosage: ) . Location: JAPAN , 64 years of age, . During the same period patient was treated with CHLOROFORM (View Chloroform Review and Chloroform Label ).

5344531-9 |
on May 23, 2007 Female patient from JAPAN , 41 years of age, was treated with Triazolam (View Usage). . Triazolam dosage: . During the same period patient was treated with DIAZEPAM (View Diazepam Review and Diazepam Label ), MORPHINE (View Morphine Review and Morphine Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), EPHEDRINE (View Ephedrine Review and Ephedrine Label ), NOREPHEDRINE HYDROCHLORIDE (View Norephedrine Hydrochloride Review and Norephedrine Hydrochloride Label ), DIHYDROCODEINE BITARTRATE INJ (View Dihydrocodeine Bitartrate Inj Review and Dihydrocodeine Bitartrate Inj Label ).

5344529-0 |
on May 23, 2007 Female patient from JAPAN , 71 years of age, was treated with Triazolam (View Usage). . Triazolam dosage: . During the same period patient was treated with DIAZEPAM (View Diazepam Review and Diazepam Label ), MORPHINE (View Morphine Review and Morphine Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), EPHEDRINE (View Ephedrine Review and Ephedrine Label ), NOREPHEDRINE HYDROCHLORIDE (View Norephedrine Hydrochloride Review and Norephedrine Hydrochloride Label ), DIHYDROCODEINE BITARTRATE INJ (View Dihydrocodeine Bitartrate Inj Review and Dihydrocodeine Bitartrate Inj Label ).

5344461-2 |
Patient was taking Triazolam (View Usage). on May 23, 2007 from JAPAN Additional patient health information: Male patient , 60 years of age, . Triazolam dosage: . During the same period patient was treated with ETHANOL (View Ethanol Review and Ethanol Label ).

5333433-X | Anxiety, Bipolar Ii Disorder, Depression, Suicidal Ideation
Adverse event was reported on May 22, 2007 by a Male patient taking Triazolam (View Usage) (Dosage: .25 X 2 Daily Po To Present Daily Dose) was diagnosed with initial insomnia and. Location: UNITED STATES , weighting 200.0 lb, Patient had the following side effects: anxiety (What is anxiety?), bipolar ii disorder, depression (What is depression?), suicidal ideation. Patient was hospitalized.

5308566-4 | Abnormal Sleep-related Event, Aggression, Anxiety, Cognitive Disorder, Confusional State, Dysgraphia, Fall, Head Injury
on Apr 23, 2007 Female patient from UNITED STATES , weighting 122.0 lb, was diagnosed with insomnia and was treated with Triazolam (View Usage). After Triazolam was administered, patient had the following side effects: abnormal sleep-related event, aggression, anxiety (What is anxiety?), cognitive disorder, confusional state, dysgraphia, fall (What is fall?), head injury. Triazolam dosage: .25 2 Po .25 1 Po.

5219966-5 | Anxiety, Eating Disorder, Headache, Insomnia, Vomiting
on Jan 15, 2007 Male patient from MEXICO , weighting 176.4 lb, was diagnosed with insomnia and was treated with Triazolam (View Usage). Patient experienced the following unwanted or unexpected effects: anxiety (What is anxiety?), eating disorder (What is eating disorder?), headache (What is headache?), insomnia, vomiting. Triazolam dosage: .

5179579-0 | Apnoea, Electroencephalogram Abnormal, Lung Disorder, Respiratory Rate Increased, Sinus Tachycardia, Stupor, Suicide Attempt, Tonic Convulsion
Patient was taking Triazolam (View Usage). Patient had the following side effects: apnoea, electroencephalogram abnormal, lung disorder, respiratory rate increased, sinus tachycardia, stupor, suicide attempt, tonic convulsion on Nov 29, 2006 from JAPAN Additional patient health information: Female patient , 43 years of age, . Triazolam dosage: . During the same period patient was treated with ALPRAZOLAM (View Alprazolam Review and Alprazolam Label ), AMOXAPINE (View Amoxapine Review and Amoxapine Label ), PAROXETINE (View Paroxetine Review and Paroxetine Label ), RILMAZAFONE (RILMAZAFONE) (View Rilmazafone (rilmazafone) Review and Rilmazafone (rilmazafone) Label ). Patient was hospitalized.

5151238-X | Abasia, Fall, Sleep Walking, Spinal Fracture
Adverse event was reported on Nov 13, 2006 by a Female patient taking Triazolam (View Usage) (Dosage: .25 2 Tabs @ Bedtime) was diagnosed with insomnia and. Location: UNITED STATES , 69 years of age, weighting 125.0 lb, After Triazolam was administered, patient had the following side effects: abasia, fall (What is fall?), sleep walking, spinal fracture.

5111642-2 | Amnesia, Impaired Driving Ability
on Sep 20, 2006 Female patient from UNITED STATES , 47 years of age, weighting 165.0 lb, was diagnosed with sleep disorder (What is sleep disorder?) and was treated with Triazolam (View Usage). Patient experienced the following unwanted or unexpected effects: amnesia, impaired driving ability. Triazolam dosage: 2 Tablets Daily-nitetime- Po.

5108220-8 | Bipolar I Disorder, Logorrhoea, Road Traffic Accident
on Aug 14, 2006 Male patient from JAPAN , weighting 153.9 lb, was diagnosed with insomnia, benign prostatic hyperplasia and was treated with Triazolam (View Usage). Patient had the following side effects: bipolar i disorder, logorrhoea, road traffic accident. Triazolam dosage: . During the same period patient was treated with SL770499 (View Sl770499 Review and Sl770499 Label ). Patient was hospitalized.

5097389-X | Bipolar I Disorder
Patient was taking Triazolam (View Usage). After Triazolam was administered, patient had the following side effects: bipolar i disorder on Aug 14, 2006 from JAPAN Additional patient health information: Male patient , weighting 153.9 lb, was diagnosed with insomnia, benign prostatic hyperplasia and. Triazolam dosage: . During the same period patient was treated with SL770499 (View Sl770499 Review and Sl770499 Label ). Patient was hospitalized.

5053473-8 | Blister, Brain Oedema, Bronchopneumonia, Haemorrhage Subcutaneous, Intracardiac Thrombus, Pulmonary Haemorrhage, Pulmonary Oedema, Skin Exfoliation
Adverse event was reported on Jun 28, 2006 by a Male patient taking Triazolam (View Usage) (Dosage: ) . Location: JAPAN , 40 years of age, Patient experienced the following unwanted or unexpected effects: blister, brain oedema, bronchopneumonia, haemorrhage subcutaneous, intracardiac thrombus, pulmonary haemorrhage, pulmonary oedema, skin exfoliation.

5043141-0 | Eyelid Ptosis
on Jun 13, 2006 Female patient from JAPAN , 50 years of age, was diagnosed with ill-defined disorder and was treated with Triazolam (View Usage). Patient had the following side effects: eyelid ptosis. Triazolam dosage: Oral. During the same period patient was treated with VIT K CAP (View Vit K Cap Review and Vit K Cap Label ).

4968288-6 | Blood Creatine Phosphokinase Increased, Depressed Level Of Consciousness, Myalgia, Nausea, Oedema, Suicide Attempt
on Mar 22, 2006 Female patient from JAPAN , 47 years of age, was diagnosed with ill-defined disorder and was treated with Triazolam (View Usage). After Triazolam was administered, patient had the following side effects: blood creatine phosphokinase increased, depressed level of consciousness, myalgia, nausea (What is nausea?), oedema, suicide attempt. Triazolam dosage: Oral. During the same period patient was treated with IMATINIB MESILATE (IMATINIB MESILATE) (Oral) (View Imatinib Mesilate (imatinib Mesilate) Review and Imatinib Mesilate (imatinib Mesilate) Label ), BROTIZOLAM (BROTIZOLAM) (Oral) (View Brotizolam (brotizolam) Review and Brotizolam (brotizolam) Label ). Patient was hospitalized.

4932256-0 | Amnesia, Apathy, Aphasia, Asthenia, Brain Scan Abnormal, Carbon Monoxide Poisoning, Carboxyhaemoglobin Increased, Central Nervous System Lesion, Depressed Level Of Consciousness
Patient was taking Triazolam (View Usage). Patient experienced the following unwanted or unexpected effects: amnesia, apathy, aphasia (What is aphasia?), asthenia, brain scan abnormal, carbon monoxide poisoning (What is carbon monoxide poisoning?), carboxyhaemoglobin increased, central nervous system lesion, depressed level of consciousness on Feb 15, 2006 from JAPAN Additional patient health information: Female patient , 36 years of age, was diagnosed with ill-defined disorder and. Triazolam dosage: .

4781461-5 | Abnormal Behaviour, Asterixis, Blood Creatine Phosphokinase Increased, Blood Thyroid Stimulating Hormone Increased, Electroencephalogram Abnormal, Emotional Distress, Encephalitis, Eye Disorder
Adverse event was reported on Sep 14, 2005 by a Female patient taking Triazolam (View Usage) (Dosage: 0.25 Mg, Oral) was diagnosed with ill-defined disorder and. Location: JAPAN , 67 years of age, Patient had the following side effects: abnormal behaviour, asterixis, blood creatine phosphokinase increased, blood thyroid stimulating hormone increased, electroencephalogram abnormal, emotional distress, encephalitis (What is encephalitis?), eye disorder. Patient was hospitalized.

4673018-1 | Anaemia, Bedridden, Blood Albumin Decreased, Blood Alkaline Phosphatase Increased, Blood Cholinesterase Increased, Blood Lactate Dehydrogenase Increased, Candida Sepsis, Catheter Related Infection, Cholecystitis Acute
on May 12, 2005 Female patient from , 86 years of age, was diagnosed with insomnia, toxic epidermal necrolysis, hyperuricaemia and was treated with Triazolam (View Usage). After Triazolam was administered, patient had the following side effects: anaemia, bedridden, blood albumin decreased, blood alkaline phosphatase increased, blood cholinesterase increased, blood lactate dehydrogenase increased, candida sepsis, catheter related infection, cholecystitis acute. Triazolam dosage: Oral. During the same period patient was treated with METHYLPREDNISOLONE (1000 Mg Intravenous) (View Methylprednisolone Review and Methylprednisolone Label ), PROBENECID (Oral) (View Probenecid Review and Probenecid Label ). Patient was hospitalized.

4665159-X | Anaemia, Blood Lactate Dehydrogenase Increased, Blood Urea Nitrogen/creatinine Ratio Increased, Candidiasis, Cholecystitis Acute, Clostridium Colitis, Condition Aggravated, Diverticulum Intestinal Haemorrhagic, Erosive Oesophagitis
on May 06, 2005 Female patient from , 86 years of age, was diagnosed with insomnia, toxic epidermal necrolysis, hyperuricaemia and was treated with Triazolam (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, blood lactate dehydrogenase increased, blood urea nitrogen/creatinine ratio increased, candidiasis, cholecystitis acute, clostridium colitis, condition aggravated, diverticulum intestinal haemorrhagic, erosive oesophagitis. Triazolam dosage: Oral. During the same period patient was treated with METHYLPREDNISOLONE (1000 Mg, Intravenous) (View Methylprednisolone Review and Methylprednisolone Label ), PROBENECID (Oral) (View Probenecid Review and Probenecid Label ). Patient was hospitalized.

4647232-5 | Anaemia, Bedridden, Blood Albumin Decreased, Blood Alkaline Phosphatase Increased, Blood Lactate Dehydrogenase Increased, Blood Urea Increased, Candida Sepsis, Catheter Related Infection, Cholecystitis Acute
Patient was taking Triazolam (View Usage). Patient had the following side effects: anaemia, bedridden, blood albumin decreased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, blood urea increased, candida sepsis, catheter related infection, cholecystitis acute on Apr 13, 2005 from Additional patient health information: Female patient , 86 years of age, was diagnosed with insomnia, toxic epidermal necrolysis, hyperuricaemia and. Triazolam dosage: Oral. During the same period patient was treated with METHYLPREDNISOLONE SODIUM SUCCINATE (1000 Mg, Intravenous) (View Methylprednisolone Sodium Succinate Review and Methylprednisolone Sodium Succinate Label ), PROBENECID (Oral) (View Probenecid Review and Probenecid Label ). Patient was hospitalized.

4635479-3 | Blood Pressure Increased, Heart Rate Decreased, Thyroidectomy
Adverse event was reported on Mar 31, 2005 by a Female patient taking Triazolam (View Usage) (Dosage: 0.25 Mg (0.25 Mg, 1 In 1 D), Oral) was diagnosed with sleep disorder (What is sleep disorder?) and. Location: , 72 years of age, weighting 110.0 lb, After Triazolam was administered, patient had the following side effects: blood pressure increased, heart rate decreased, thyroidectomy. Patient was hospitalized.

4620620-9 | Blood Pressure Increased, Heart Rate Decreased, Thyroidectomy
on Mar 11, 2005 Female patient from , 72 years of age, weighting 110.0 lb, was diagnosed with sleep disorder (What is sleep disorder?) and was treated with Triazolam (View Usage). Patient experienced the following unwanted or unexpected effects: blood pressure increased, heart rate decreased, thyroidectomy. Triazolam dosage: 025 Mg (0.25 Mg, 1 In 1 D), Oral. Patient was hospitalized.

4613238-5 | Abdominal Pain, Acute Prerenal Failure, Blood Pressure Systolic Increased, Body Temperature Decreased, Dehydration, Haemodialysis, Intentional Misuse, Rhabdomyolysis, Suicide Attempt
on Mar 02, 2005 Male patient from , 47 years of age, was diagnosed with ill-defined disorder and was treated with Triazolam (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), acute prerenal failure, blood pressure systolic increased, body temperature decreased, dehydration, haemodialysis, intentional misuse, rhabdomyolysis, suicide attempt. Triazolam dosage: 2.5 Mg, Oral. During the same period patient was treated with FLUNITRAZEPAM (FLUNITRAZEPAM) (Oral) (View Flunitrazepam (flunitrazepam) Review and Flunitrazepam (flunitrazepam) Label ), PHENOBARBITAL TAB (Oral) (View Phenobarbital Tab Review and Phenobarbital Tab Label ), LORAZEPAM (Oral) (View Lorazepam Review and Lorazepam Label ), TIZANIDINE HCL (Oral) (View Tizanidine Hcl Review and Tizanidine Hcl Label ), ZOPICLONE (ZOPICLONE) (Oral) (View Zopiclone (zopiclone) Review and Zopiclone (zopiclone) Label ). Patient was hospitalized.

4548059-5 | Abnormal Behaviour, Completed Suicide, Hallucination, Overdose, Pyromania, Thinking Abnormal
Patient was taking Triazolam (View Usage). After Triazolam was administered, patient had the following side effects: abnormal behaviour, completed suicide, hallucination, overdose, pyromania, thinking abnormal on Jan 04, 2005 from Additional patient health information: Female patient , 49 years of age, weighting 120.0 lb, was diagnosed with sleep disorder (What is sleep disorder?) and. Triazolam dosage: .